Opko Health (OPK) and Haemonetics (HAE) Financial Survey

Opko Health (OPK) and Haemonetics (HAE) Financial Survey

Opko Health and Haemonetics are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations and risk. Opko Health currently has a consensus price target of $12.10, suggesting a potential upside of 270.03%.

from Biotech News